Analytical Data
-
Gene name
SCGB3A1
- Application
-
Alternative Names
SCGB3A1；HIN1；PNSP2；UGRP2；Secretoglobin family 3A member 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96QR1
-
Expression Region
1-104aa
-
AA Sequence
MKLAALLGLC VALSCSSAAA FLVGSAKPVA QPVAALESAA EAGAGTLANP LGTLNPLKLL LSSLGIPVNH LIEGSQKCVA ELGPQAVGAV KALKALLGAL TVFG
-
Molecular Weight
35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SCGB3A1, also known as Secretoglobin Family 3A Member 1, is a protein that belongs to the secretoglobin superfamily, which is primarily involved in various biological functions, including immune response modulation, anti-inflammatory activities, and hormone transport. Research has highlighted the significance of SCGB3A1 in various physiological and pathological processes, including its potential role in lung function and the pathogenesis of respiratory diseases. Studies suggest that SCGB3A1 may exhibit protective properties against oxidative stress and inflammation in lung tissues, making it a focal point in both basic and applied biomedical research. The recombinant expression of SCGB3A1 has facilitated investigations into its structure-function relationships, therapeutic potentials, and varied interactions with other biomolecules. Moreover, understanding the mechanisms by which SCGB3A1 operates can provide insights into developing targeted therapies for conditions like asthma, chronic obstructive pulmonary disease, and other inflammatory disorders. As such, SCGB3A1 has emerged as a promising candidate for research aimed at uncovering new treatment strategies and enhancing our understanding of respiratory health and disease.
